FDA Brief

Company record

K. Boeun Pharmaceutical Co., Ltd.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about K. Boeun Pharmaceutical Co., Ltd..

Warning letters

  1. K. Boeun Pharmaceutical Co., Ltd.

    K. Boeun Pharmaceutical's OTC drugs were cited for CGMP violations, including missing identity tests for DEG/EG-risk components and inadequate quality unit.

    High risk